Alvogen Pine Brook Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALVOGEN PINE BROOK, and what generic and branded alternatives to ALVOGEN PINE BROOK drugs are available?
ALVOGEN PINE BROOK has one approved drug.
There is one tentative approval on ALVOGEN PINE BROOK drugs.
Summary for Alvogen Pine Brook
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Alvogen Pine Brook: | See patent lawsuits for Alvogen Pine Brook |
| PTAB Cases with Alvogen Pine Brook as petitioner: | See PTAB cases with Alvogen Pine Brook as petitioner |
Drugs and US Patents for Alvogen Pine Brook
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen Pine Brook | BOSENTAN | bosentan | TABLET;ORAL | 206002-001 | Apr 26, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Alvogen Pine Brook | BOSENTAN | bosentan | TABLET;ORAL | 206002-002 | Apr 26, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
